Originally published on 1/29/26

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices they will be negotiating this year. These negotiations come after President Joe Biden’s Inflation Reduction Act of 2022 lowered the price of 15 different drugs this year, and are expected to help seniors on the government-funded health insurance program get the medications they need at a much lower rate. Below, we share which drugs have been selected by the government, along with details on when seniors can expect to purchase them at the lower rate. 

What to know about the new Medicare drug plan

On Tuesday, January 27, President Trump and CMS held a press conference to announce  that they were working with prescription drug companies to lower the cost of 15 medications. It’s the third time the government has done something of this nature, and is a direct result of the Medicare Drug Price Negotiation Program, which was created in President Biden’s Inflation Reduction Act. 

“For too long, seniors and taxpayers have paid the price for skyrocketing prescription drug costs,” CMS Administrator Mehmet Oz, MD, said in a statement. “Under President Trump’s leadership, CMS is taking strong action to target the most expensive drugs in Medicare, negotiate fair prices and make sure the system works for patients—not special interests. This approach delivers real savings while strengthening accountability across the program.”

Prior to Tuesday’s announcement, all drugs selected for the Medicare Drug Price Negotiation Program were covered under Medicare Part D—which normally covers seniors’ prescription costs. Now, as part of this new renegotiation with pharmaceutical companies, some drugs covered by Medicare Part B—which normally covers outpatient procedure costs—are expected to be included as well.

This is a massive shift in coverage and cost, and is expected to help seniors pay for the medications they need. AARP CEO Dr. Myechia Minter-Jordan called it a “significant step forward,” according to ABC News. 

“Older Americans across the political spectrum consistently say that lowering drug prices is a top priority, and we thank the Administration for protecting Medicare’s ability to meet that need,” Minter-Jordan said. 

The full list: 15 prescription drugs with lower prices coming in 2028

Which medications can you expect to pay less for? 

• Anoro Ellipta, a prescription inhaler that helps people with Chronic Obstructive Pulmonary Disease. 
• Biktarvy, a medication that helps treat HIV-1 in adults and children. 
• Botox, an injectable that can help treat wrinkles, manage migraines and help control muscle spasms. 
• Cimzia, a medication that helps treat Crohn’s disease, rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis and plaque psoriasis. 
• Cosentyx, an injectable that treats moderate-to-severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis. 
• Entyvio, a medication that helps treat Crohn’s disease and ulcerative colitis. 
• Erleada, a medication that helps treat prostate cancer. 
• Kisqali, a medication that helps treat hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. 
• Lenvima, a medication that helps treat thyroid, kidney, liver and uterine cancer. 
• Orencia, an infusion or injection that helps treat rheumatoid arthritis, psoriatic arthritis and polyarticular juvenile idiopathic arthritis. 
• Rexulti, a medication that helps manage schizophrenia and agitation in adults with dementia. 
• Trulicity, a weekly GLP-1 that helps treat type 2 diabetes. 
• Verzenio, a medication that helps treat hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.
• Xeljanz, a medication that helps treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis and polyarticular juvenile idiopathic arthritis. 
• Xolair, an injectable that helps treat asthma, chronic spontaneous urticaria, food allergies and chronic rhinosinusitis with nasal polyps. 

As of publication, there is no news on how much these medications will cost seniors once the negotiations between the government and the drug companies are over. 

When the new Medicare drug prices will take affect 

The 15 medications mentioned above will be reduced in price starting on January 1, 2028.

Link to original: https://www.womansworld.com/healthcare/medicare-drug-plans-2026